PromarkerD launched in Spain

Proteomics International has officially launched PromarkerD in Spain under a deal with Patia Europe.

The PromarkerD test system is the first test globally that is capable of predicting the onset of diabetic kidney disease.

The exclusive licence agreement with Patia Europe for Spain is for two years and Proteomics International will receive a royalty on each test sold.

The launch coincides with PromarkerD being showcased at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, 16-20 September 2019.

The launch is a pivotal milestone for Proteomics International, providing a platform to broaden awareness of PromarkerD, potentially accelerating the execution of additional licensing transactions.

Media Release